kcusiap

Sarajevo, Lecture Hall of the Clinical Centre of the University of Sarajevo (NIR)

5-7 November 2014

Organizers:
British Division of the International Academy of Pathology (BDIAP), United Kingdom
Department of Pathology, Clinical Centre of the University of Sarajevo, Bosnia and Herzegovina

Under the auspices of
Institute for Scientific Work and Research
Clinical Centre of the University of Sarajevo


WELCOME

Dear colleagues and friends,

It is again our great pleasure to announce the 8th Bryan Warren School Pathology that will be held in Sarajevo on November 5-7, 2014 organized by the Department of Pathology, Clinical Centre of the University of Sarajevo and the British Division of the International Academy of Pathology (BDIAP).

The main topic of the School will be lung and mediastinal pathology, both of which represent enormously challenging and important fields. The main lecturers will be two distinguished and well experienced histopathologists: Dr. Paul Cane FRCPath (Guy’s & St. Thomas’ NHS Foundation Trust, London, United Kingdom) and Dr. Michael den Bakker (Maasstad Hospital, Rotterdam, Netherlands)

The School objectives remain the same as all previous years: to give a brief overview of the most important topics in lung and mediastinal pathology and to cover the practical issues, particularly those relevant for young specialists and residents in pathology as well as for clinicians.

We sincerely hope that the School again shall meet your expectations and it will certainly depend on your active participation.

We look forward to meeting you in Sarajevo!

Nurija Bilalović, MD, PhD
Head Department of Pathology
Clinical Centre of the University of Sarajevo


FACULTY

Dr. Paul Cane FRCPath (Guy’s & St. Thomas’ NHS Foundation Trust, London, UK)

Dr. Michael den Bakker (Maasstad Hospital, Rotterdam, the Netherlands)

LOCAL COURSE FACULTY

President: Dr. Nurija Bilalović
Executive secretary and contact: Dr. Semir Vranić
Members:
Dr. Damir Aganović
Dr. Zoran Hadžiahmetović
Dr. Faruk Skenderi
Dr. Dalma Udovičić-Gagula
Dr. Adela Ćimić


REGISTRATION AND CONTACT

To register, download the [REGISTRATION FORM], complete it and send it by e-mail to: [email protected]

Registration fee: 50 EUR or 100 BAM (to be paid at registration desk at venue) 

 Dr. Semir Vranić

Department of Pathology
Clinical Centre of the University of Sarajevo
Bolnička 25
BA-71000 Sarajevo
Phone/fax. ++387 33 297 826
Phone : ++387 61 559 601
E-mail: [email protected]
Web sites: www.bosnianpathology.org, http://www.bdiap.org, http://www.kcus.ba


PROGRAM (updated 9 September 2014)

DAY 1 – MORNING

(lung neoplasia)

08.00 – 09.00Registration and Opening Ceremony
09.00 – 09.45Introduction
09.45 – 10.30Adenocarcinoma and preinvasive lesions
10.30 – 10.45BREAK
10.45 – 11.30Other non-small cell carcinomas
11.30 – 12.15Slide seminar
12.15 – 12.30Biomarker testing in NSCLC (Dr Luka Brčić, sponsored by Roche)
12.30 – 13.15LUNCH

DAY 1- AFTERNOON

(Mediastinum)

13.15 – 13.30 introduction:
13.30 – 14.15Thymoma
14.15 – 14.45Other thymic and mediastinal pathology – part 1
14.45 – 15.00BREAK
15.00 – 15.30Other thymic and mediastinal pathology – part 2
15.30 – 16.45Slide seminar

 

DAY 2 – MORNING

(Other primary lung tumours)

09.00 – 09.45Neuroendocrine tumours
09.45 – 10.30Other tumours
10.30 – 10.45BREAK
10.45 – 11.30Practical guide to cut up, reporting and biomarker testing
11.30 – 12.30Slide seminar
12.30 – 13.30lunch

DAY 2 – AFTERNOON

(Non-neoplastic lung)

13.30 – 14.15Introduction
14.15 – 14.45Congenital lesions
14.45 – 15.00BREAK
15.00 – 15.30Interstitial lung disease 1
15.30 – 16.00Interstitial lung disease 2
16.00 –17.00Slide seminar

 

DAY 3

(Lymphoproliferative lesions and pleura)

09.00 – 09.45Lymphoproliferative lesions
09.45 – 10.30Introduction and benign pleural disease
10.30 – 10.45BREAK
10.45 – 11.15Mesothelioma
11.15 – 11.45Other pleural malignancy
11.45 – 12.15Slide seminar

Lecture Outlines

Day 1 AM – Lung cancer

Background
• Anatomy
• Epidemiology
• Staging
• Treatment
• Biomarkers

Adenocarcinoma
• Patterns
• Preinvasive lesions
• Biomarker testing
• Future

Other non-small cell carcinoma
• Squamous cell carcinoma
• Large cell carcinoma
• Pleomorphic and sarcomatoid
• Biomarkers

Slide Seminar NSCLC
(10 cases)

Day 2 AM – Other lung neoplasia

Neuroendocrine tumours
• Small cell
• Carcinoid
• DIPNEC
• Large cell NEC

Other tumours
• Salivary gland tumours
• Papilloma
• Sclerosing pneumocytoma
• IMT
• Hamartoma
• Sarcoma of blood vessels
• Metastases

Practical guide to cut up, reporting and biomarker testing
• Cut up
• Resection reporting
• Scheme

Case studies
(10 cases)

DAY 3 AM – Pleura

Lymphoproliferative Disease
• Marginal zone lymphoma
• DLBCL and Hodgkin’s Disease
• Lymphomatoid granulomatosis
• Castleman’s Disease

Introduction to Pleura
• Anatomy
• Asbestos
• Benign pleura changes
• Cytology

Mesothelioma
• Epidemiology
• Classification and staging
• Pathology inc immuno
• Treatment options

Michael’s lecture

Case studies
(3 Cases each for LPDs and pleura and 4 for Michael)


COURSE MATERIALS

The digital slides will be available online until about 25 November 2014.

[PDF] Slide seminar: Thymic & Mediastinal pathology (updated 15 November 2014)
Click on the thumbnails within the PDF to access the virtual slides!
Sign in as a Guest user

[PDF] Slide seminar: Interstitial Lung Disease
Click on the images and thumbnails within the PDF to access the virtual slides!
Sign in as a Guest user

[PDF] Slide seminar: Rare lung tumors (updated 15 November 2014)
Click on the images and thumbnails within the PDF to access the virtual slides!
Sign in as a Guest user

[PDF] Slide seminar: Non-small cell lung carcinoma; Neuroendocrine tumours; Pleura; Lymphoid proliferations
Click on the slide ID number within the PDF to access the virtual slides!
Sign in as a Guest user

[PDF] Slide seminar: Pediatric lung disease (updated 15 November 2014)
Click on the slide ID number within the PDF to access the virtual slides!
Sign in as a Guest user


PHOTOS

{gallery}BBSP/BWSP-2014/photo{/gallery}


REPORT FROM FACULTY

http://bdiap.org/Newsletter/BDIAP_Issue11.pdf See page 7